PureIMS receives a grant of € 41.028,58 to initiate the development of a new dry powder inhaler (DPI). This new DPI will contain an innovative dispersion mechanism to enable delivery of medicines such as antibiotics, vaccines, and biologics. Unlike current devices, it will be user-friendly and suitable for vulnerable groups like children and elderly […]
Category: Status update
PureIMS winning the LIFE Science Innovation Award!
Tuesday September 26 was an exciting day for the PureIMS team. Not only was the first cohort of volunteers dosed in the penultimate Levodopa Cyclops™ bioavailability study, we were also honored with the LIFE Science Innovation Award. LIFE Cooperative, very successfully organizing their annual conference and award ceremony, is a cooperation of 50+ LifeScience and MedTech SMEs […]
PureIMS present at DDL2022
PureIMS will be present at the Drug Delivery to the Lungs Conference 2022 in Edinburgh. Please visit our stand (246) and have a chat. We will be more than happy to tell you everything about our Cyclops™ single-use dry powder inhaler and hear all about your interesting projects too! Furthermore, check out our posters on […]
PureIMS present at DDL
PureIMS will be present at the Drug Delivery to the Lungs Conference 2019 in Edinburgh. Please visit our stand (507)!